First Horizon Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-282
Closed -$2.58K 2452
2023
Q1
$2.58K Sell
282
-291
-51% -$3.72K ﹤0.01% 2025
2022
Q4
$6.54K Buy
573
+165
+40% +$2.44K ﹤0.01% 1712
2022
Q3
$7K Sell
408
-107
-21% -$2.3K ﹤0.01% 1636
2022
Q2
$11K Buy
515
+348
+208% +$9.65K ﹤0.01% 1530
2022
Q1
$6K Buy
167
+21
+14% +$818 ﹤0.01% 1233
2021
Q4
$7K Sell
146
-2
-1% -$104 ﹤0.01% 1641
2021
Q3
$9K Buy
148
+2
+1% +$152 ﹤0.01% 1560
2021
Q2
$13K Buy
146
+19
+15% +$1.51K ﹤0.01% 1250
2021
Q1
$9K Sell
127
-10
-7% -$776 ﹤0.01% 1316
2020
Q4
$10K Sell
137
-110
-45% -$6.37K ﹤0.01% 1069
2020
Q3
$9K Hold
247
﹤0.01% 1026
2020
Q2
$9K Sell
247
-47
-16% -$1.34K ﹤0.01% 1029
2020
Q1
$6K Buy
294
+108
+58% +$2.42K ﹤0.01% 1061
2019
Q4
$4K Hold
186
﹤0.01% 1295
2019
Q3
$4K Buy
+186
New +$5.15K ﹤0.01% 1288

Other funds holding CDNA

First Horizon Advisors's CDNA Position: Q2 2023 in Review

First Horizon Advisors sold out of CareDx (CDNA) in Q2 2023, closing a stake of 282 shares — an estimated $2.58K sold.

First Horizon Advisors first reported a position in CDNA in Q3 2019 and held it in 15 quarters. The position peaked at $13K in Q2 2021. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2023.

  • First Horizon Advisors reported no remaining CareDx position as of Q2 2023 after selling out during the quarter.
  • First Horizon Advisors sold 282 CareDx shares in Q2 2023, an estimated $2.58K.
  • First Horizon Advisors first reported a position in CareDx in Q3 2019 and held it in 15 quarters.
  • First Horizon Advisors's CareDx position peaked at $13K in Q2 2021.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2023.

Based on First Horizon Advisors's 13F filing for Q2 2023, filed 3 Aug 2023.